4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-25-001842
CEO and CFO bought 2,500 shares at $12.51 ($31,275)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2025-01-10 | Purchase | +2,500 | $12.51 | $31,275 | 5,552,502 | D |
| Open-market purchases · 2,500 sh · avg $12.51 · $31,275 | |||||||
Loading xslF345X05/ownership.xml…